<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01302080</url>
  </required_header>
  <id_info>
    <org_study_id>A0501093</org_study_id>
    <secondary_id>SPRITES</secondary_id>
    <nct_id>NCT01302080</nct_id>
  </id_info>
  <brief_title>Sertraline Pediatric Registry for the Evaluation of Safety (SPRITES)</brief_title>
  <acronym>SPRITES</acronym>
  <official_title>SPRITES: SERTRALINE PEDIATRIC REGISTRY FOR THE EVALUATION OF SAFETY A NON-INTERVENTIONAL, LONGITUDINAL, COHORT STUDY TO EVALUATE THE EFFECTS OF LONG-TERM SERTRALINE TREATMENT IN CHILDREN AND ADOLESCENTS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pfizer's Upjohn has merged with Mylan to form Viatris Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pfizer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the long-term impact of treatment with sertraline on aspects of cognitive,&#xD;
      emotional and physical development and pubertal maturation in pediatric subjects ages 6 to 16&#xD;
      years (inclusive) with a diagnosis of anxiety disorder, depressive disorder or obsessive&#xD;
      compulsive disorder.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purposive sample: patients are not randomly selected, that is, he or she must meet certain&#xD;
      inclusion criteria in order to qualify as a potential study participant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 4, 2012</start_date>
  <completion_date type="Actual">September 9, 2020</completion_date>
  <primary_completion_date type="Actual">September 9, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 3</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 6</measure>
    <time_frame>Baseline, Month 6</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 12</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 18</measure>
    <time_frame>Baseline, Month 18</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 24</measure>
    <time_frame>Baseline, Month 24</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 30</measure>
    <time_frame>Baseline, Month 30</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Trails B at Month 36</measure>
    <time_frame>Baseline, Month 36</time_frame>
    <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 3</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 6</measure>
    <time_frame>Baseline, Month 6</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 12</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 18</measure>
    <time_frame>Baseline, Month 18</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 24</measure>
    <time_frame>Baseline, Month 24</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 30</measure>
    <time_frame>Baseline, Month 30</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 36</measure>
    <time_frame>Baseline, Month 36</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 3</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 6</measure>
    <time_frame>Baseline, Month 6</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 12</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 18</measure>
    <time_frame>Baseline, Month 18</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 24</measure>
    <time_frame>Baseline, Month 24</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 30</measure>
    <time_frame>Baseline, Month 30</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 36</measure>
    <time_frame>Baseline, Month 36</time_frame>
    <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 3</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on centers for disease control (CDC) norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 6</measure>
    <time_frame>Baseline, Month 6</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 12</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 18</measure>
    <time_frame>Baseline, Month 18</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 24</measure>
    <time_frame>Baseline, Month 24</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 30</measure>
    <time_frame>Baseline, Month 30</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Height at Month 36</measure>
    <time_frame>Baseline, Month 36</time_frame>
    <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 3</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 6</measure>
    <time_frame>Baseline, Month 6</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 12</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 18</measure>
    <time_frame>Baseline, Month 18</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 24</measure>
    <time_frame>Baseline, Month 24</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 30</measure>
    <time_frame>Baseline, Month 30</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Weight at Month 36</measure>
    <time_frame>Baseline, Month 36</time_frame>
    <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 3</measure>
    <time_frame>Baseline, Month 3</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 6</measure>
    <time_frame>Baseline, Month 6</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 12</measure>
    <time_frame>Baseline, Month 12</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 18</measure>
    <time_frame>Baseline, Month 18</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 24</measure>
    <time_frame>Baseline, Month 24</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 30</measure>
    <time_frame>Baseline, Month 30</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Body Mass Index (BMI) at Month 36</measure>
    <time_frame>Baseline, Month 36</time_frame>
    <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary: Number of Participants With Tanner Staging Evaluation at Baseline: All Males</measure>
    <time_frame>Baseline (prior to or within 45 Days of initiating treatment, if exposed) and after parental/guardian provided permission and assent</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 3: All Males</measure>
    <time_frame>Month 3</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 6: All Males</measure>
    <time_frame>Month 6</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 12: All Males</measure>
    <time_frame>Month 12</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 18: All Males</measure>
    <time_frame>Month 18</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 24: All Males</measure>
    <time_frame>Month 24</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 30: All Males</measure>
    <time_frame>Month 30</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 36: All Males</measure>
    <time_frame>Month 36</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Baseline: All Females</measure>
    <time_frame>Baseline (prior to or within 45 Days of initiating treatment, if exposed) and after parental/guardian provided permission and assent</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 3: All Females</measure>
    <time_frame>Month 3</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 6: All Females</measure>
    <time_frame>Month 6</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 12: All Females</measure>
    <time_frame>Month 12</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 18: All Females</measure>
    <time_frame>Month 18</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 24: All Females</measure>
    <time_frame>Month 24</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 30: All Females</measure>
    <time_frame>Month 30</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Tanner Staging Evaluation at Month 36: All Females</measure>
    <time_frame>Month 36</time_frame>
    <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants in Each Category of Clinical Global Impression-Improvement (CGI-I) Scale at Month 3, 6, 12, 18, 24, 30 and 36</measure>
    <time_frame>Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
    <description>CGI-I scale was a 7-point scale used to rate improvement in the participant's condition (benefits). Scale range/categories: 1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = Not changed, 5 = minimally worse, 6 = much worse, and 7 = very much worse. Higher score indicated worse condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants in Each Category of Clinical Global Impression-Tolerability (CGI-T) Scale at Month 3, 6, 12, 18, 24, 30 and 36</measure>
    <time_frame>Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
    <description>CGI-T scale was a 7-point scale used to assess the tolerability of the study medication with respect to adverse events. Scale range/categories: 1= very high, 2= high, 3= above average, 4= average, 5= low, 6= very low, and 7= extremely low. Higher score indicated less tolerability with study medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Were Responders According to Clinical Global Impression-Effectiveness (CGI-E) Scale at Month 3, 6, 12, 18, 24, 30 and 36</measure>
    <time_frame>Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
    <description>The CGI-E was the value at which the participant's therapeutic benefit and adverse impact to the study drug intersected. Firstly clinician identified the degree of therapeutic benefit on scale range: very much improved, much improved, minimally improved, unchanged or worse. Secondly, the clinician rater identified the degree to which problems with tolerability adversely impact the participant on scale range: no adverse impact, mild adverse impact, moderate adverse impact, outweighs therapeutic effect. Finally, clinician identified in which participants benefits and adverse impacts intersected. Participants were then determined to be responders or non-responders to the study medication.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants in Each Category of Clinical Global Impression-Severity (CGI-S) Scale at Baseline, Month 3, 6, 12, 18, 24, 30 and 36</measure>
    <time_frame>Baseline, Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
    <description>CGI-S scale was a 7-point scale used to assess severity of illness on a range of 1 to 7; where, 1= normal, not mentally ill, 2= borderline mentally ill, 3= mildly mentally ill, 4= moderately mentally ill, 5= markedly mentally ill, 6= severely mentally ill, and 7= among the most extremely mentally. Higher score indicated worse condition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in Child Global Assessment Scale (CGAS) at Month 3, 6, 12, 18, 24, 30 and 36</measure>
    <time_frame>Baseline, Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
    <description>CGAS was to rate the general functioning of the study participants on a numeric scale of 1 to 100, where 1= extremely impaired and 100= doing very well.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in General Health and Social Functioning Using the Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) Total Score at Month 3, 6, 12, 18, 24, 30 and 36</measure>
    <time_frame>Baseline, Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
    <description>HoNOSCA scale had 13-sub-scales used to assess general health and social functioning. 13 sub-scales were as the following: disruptive or aggressive behavior, attention deficit hyperactivity disorder (ADHD), self-harm, substance abuse, school problems, physical illness, psychosis, physical symptoms, internalizing symptoms, peer relationships, self-care, family relationships and school attendance problems. Each sub-scale had a range of 0 (no problems) to 4 (severe problems). Scores from all 13 sub-scales were summed up to give overall possible HoNOSCA total score range of 0 to 52. Higher score indicated worse condition.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">941</enrollment>
  <condition>Obsessive Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>Sertraline-treated</arm_group_label>
    <description>enrolled subjects beginning treatment for one of the study qualifying disorders with sertraline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>psychotherapy only</arm_group_label>
    <description>enrolled subjects beginning treatment for one of the study qualifying disorders with psychotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sertraline</intervention_name>
    <description>Non interventional study - drug, dose, duration etc as per USPI and clinician discretion</description>
    <arm_group_label>Sertraline-treated</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychotherapy</intervention_name>
    <description>Non-interventional study- as above</description>
    <arm_group_label>psychotherapy only</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The accessible population is children meeting inclusion/exclusion criteria from US centers&#xD;
        in various clinical settings, including the Child and Adolescent Psychiatry Trials Network&#xD;
        (CAPTN). From these, the study-eligible population (all children age 6 to 16 (inclusive)&#xD;
        with an anxiety, depressive, or obsessive-compulsive disorder, who are exposed to&#xD;
        sertraline under real-world conditions) will comprise an inception cohort of enrolled&#xD;
        subjects beginning treatment for one of the study-qualifying disorders with sertraline or&#xD;
        psychotherapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children age 6 to 16 (inclusive) with anxiety, depression, or obsessive-compulsive&#xD;
             disorder, receiving treatment in outpatient setting, and who are prescribed a new&#xD;
             prescription for sertraline to treat one of the above study-qualifying disorders or&#xD;
             beginning psychotherapy for same.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Psychotic at study entry&#xD;
&#xD;
          -  Diagnosis of bipolar disorder&#xD;
&#xD;
          -  Diagnosis of schizoaffective or schizophrenia&#xD;
&#xD;
          -  Anorexia&#xD;
&#xD;
          -  Bulimia or eating disorder not otherwise specified (NOS)&#xD;
&#xD;
          -  Autism&#xD;
&#xD;
          -  Pervasive developmental disorder&#xD;
&#xD;
          -  High risk of suicide within 2 weeks of initiating study treatment&#xD;
&#xD;
          -  Significant mental retardation&#xD;
&#xD;
          -  Taking an antidepressant medication other than sertraline, first or second generation&#xD;
             antipsychotic, lithium, psychostimulant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pfizer CT.gov Call Center</last_name>
    <role>Study Director</role>
    <affiliation>Pfizer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harmonex Neuroscience Research</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sun Valley Research Center</name>
      <address>
        <city>Imperial</city>
        <state>California</state>
        <zip>92251</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCLA Semel institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Living/Hartford Hospital</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comprehensive Psychiatric Care</name>
      <address>
        <city>Norwich</city>
        <state>Connecticut</state>
        <zip>06360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemours Children's Clinic, Dept. of Psychology and Psychiatry</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical Research Group of Central Florida</name>
      <address>
        <city>Orange City</city>
        <state>Florida</state>
        <zip>32763</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harmonex Neuroscience of Pensacola</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida - Rothman Center</name>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgia Regents University Augusta</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute for Behavioral Medicine, LLC</name>
      <address>
        <city>Smyrna</city>
        <state>Georgia</state>
        <zip>30080</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Behavioral Health</name>
      <address>
        <city>Plainfield</city>
        <state>Illinois</state>
        <zip>60585</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kansas School of Medicine/Dept. of Psychiatry</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160-7341</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Service and Guidance Center</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kennedy Krieger Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neuroscientific Insights</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20852</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Debora A. LaMonica, MD</name>
      <address>
        <city>South Yarmouth</city>
        <state>Massachusetts</state>
        <zip>02664</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center, Child Behavioral Health Research</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Comprehensive Psychiatric Associates</name>
      <address>
        <city>Gladstone</city>
        <state>Missouri</state>
        <zip>64118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint John's Clinic</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jersey Shore University Medical Center/Meridian Health</name>
      <address>
        <city>Neptune</city>
        <state>New Jersey</state>
        <zip>07753</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Specialized Hospital</name>
      <address>
        <city>Toms River</city>
        <state>New Jersey</state>
        <zip>08755</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Finger Lakes Clinical Research</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>3-C Family Services, P.A.</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27513</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center, Division of Child &amp; Adolescent Psychiatry</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott George Crowder, M.D.</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Family Center by the Falls</name>
      <address>
        <city>Chagrin Falls</city>
        <state>Ohio</state>
        <zip>44023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cincinnati Childrens Hospital and Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western Reserve University, Department of Psychiatry Child/Adolescent</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cutting Edge Research Group</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Child Guidance Resource Center</name>
      <address>
        <city>Havertown</city>
        <state>Pennsylvania</state>
        <zip>19083</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tullahoma Pediatrics PLLC</name>
      <address>
        <city>Tullahoma</city>
        <state>Tennessee</state>
        <zip>37388</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern Medical Center at Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bay Pointe Behavioral Health Service, Inc.</name>
      <address>
        <city>Friendswood</city>
        <state>Texas</state>
        <zip>77546</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midtown Psychiatry and TMS Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77007</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peter Ly MD</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77058</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Focus and Balance, LLC</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Partners, LLC</name>
      <address>
        <city>Petersburg</city>
        <state>Virginia</state>
        <zip>23805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McLean Hospital - Harvard Medical School</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://trialinfoemail.pfizer.com/pages/landing.aspx?StudyID=A0501093&amp;StudyName=Sertraline%20Pediatric%20Registry%20for%20the%20Evaluation%20of%20Safety%20%28SPRITES%29%20</url>
    <description>To obtain contact information for a study center near you, click here.</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>February 1, 2011</study_first_submitted>
  <study_first_submitted_qc>February 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2011</study_first_posted>
  <results_first_submitted>September 9, 2021</results_first_submitted>
  <results_first_submitted_qc>September 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">October 8, 2021</results_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>prospective</keyword>
  <keyword>cohort</keyword>
  <keyword>sertraline</keyword>
  <keyword>long-term impact</keyword>
  <keyword>cognition</keyword>
  <keyword>emotional and physical development</keyword>
  <keyword>pubertal maturation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sertraline</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 24, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT01302080/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 20, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/80/NCT01302080/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This was a non-interventional observational study. Participants to be enrolled were of age 6 to 16 (inclusive), exposed to sertraline (with or without psychotherapy) and exposed to psychotherapy alone under real world conditions. Participants exposed and unexposed to sertraline were followed for a maximum of 3 years.</recruitment_details>
      <pre_assignment_details>Participants switched from 1 treatment to another throughout the study, irrespective in which arm they were enrolled. Hence, number of participants for reporting arms were different at different visits.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Sertraline</title>
          <description>Participants at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to United States prescribing information (USPI) provided by their physician. Participants in this group were on sertraline only or sertraline and any other treatment. Treatment here was the one which was planned for the participants at baseline.</description>
        </group>
        <group group_id="P2">
          <title>Psychotherapy</title>
          <description>Participants, 1) who were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial/psychotherapy rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a selective serotonin reuptake inhibitor (SSRI) medication. Participants in this group were on psychotherapy only or no treatment at all.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="696">Out of 696 participants, 1 participant started treatment with another antidepressant alone or along with psychotherapy.</participants>
                <participants group_id="P2" count="245">Out of 245 participants, 2 participants started treatment with another antidepressant alone or along with psychotherapy.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="330"/>
                <participants group_id="P2" count="102"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="366"/>
                <participants group_id="P2" count="143"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrew Consent</title>
              <participants_list>
                <participants group_id="P1" count="92"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient/Family Moved</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="192"/>
                <participants group_id="P2" count="93"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Reason Missing For Discontinuation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analysis population included all participants in the database who had informed consent.</population>
      <group_list>
        <group group_id="B1">
          <title>Sertraline</title>
          <description>Participants at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician.</description>
        </group>
        <group group_id="B2">
          <title>Other Antidepressant</title>
          <description>Use of other antidepressants at baseline was a study exclusion criterion, however, a few participants were enrolled who initiated treatment with an antidepressant.</description>
        </group>
        <group group_id="B3">
          <title>Psychotherapy</title>
          <description>Participants, 1) who were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="695"/>
            <count group_id="B2" value="3"/>
            <count group_id="B3" value="243"/>
            <count group_id="B4" value="941"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.2" spread="2.9"/>
                    <measurement group_id="B2" value="14.0" spread="3.0"/>
                    <measurement group_id="B3" value="11.0" spread="2.9"/>
                    <measurement group_id="B4" value="11.9" spread="2.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="405"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="130"/>
                    <measurement group_id="B4" value="538"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="290"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="113"/>
                    <measurement group_id="B4" value="403"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="73"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="24"/>
                    <measurement group_id="B4" value="98"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="622"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="219"/>
                    <measurement group_id="B4" value="843"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="15"/>
                    <measurement group_id="B4" value="81"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="588"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="208"/>
                    <measurement group_id="B4" value="799"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="13"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 3</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician.&#xD;
At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 3</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="666"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="224"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="666"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="224"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.03" spread="2.3"/>
                    <measurement group_id="O2" value="1.23" spread="1.0"/>
                    <measurement group_id="O3" value="0.61" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="527"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="163"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.39" spread="1.6"/>
                    <measurement group_id="O2" value="-0.09" spread="0.5"/>
                    <measurement group_id="O3" value="-0.03" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 6</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 6</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="460"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="159"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.64" spread="2.2"/>
                    <measurement group_id="O2" value="-0.65" spread="1.0"/>
                    <measurement group_id="O3" value="-0.16" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 12</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 12</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="367"/>
                <count group_id="O2" value="57"/>
                <count group_id="O3" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.72" spread="2.3"/>
                    <measurement group_id="O2" value="-0.22" spread="1.4"/>
                    <measurement group_id="O3" value="-0.27" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 18</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 18</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="290"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.57" spread="1.9"/>
                    <measurement group_id="O2" value="-0.65" spread="2.2"/>
                    <measurement group_id="O3" value="-0.22" spread="2.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 24</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 24</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="247"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.44" spread="2.2"/>
                    <measurement group_id="O2" value="-1.08" spread="1.7"/>
                    <measurement group_id="O3" value="-0.18" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 30</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 30</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="209"/>
                <count group_id="O2" value="63"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.74" spread="2.1"/>
                    <measurement group_id="O2" value="-0.61" spread="2.4"/>
                    <measurement group_id="O3" value="-0.18" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Trails B at Month 36</title>
        <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
        <time_frame>Baseline, Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Trails B at Month 36</title>
          <description>Trail B test is a set of shifting task, in which participants were asked to drawn a line from number 1 to letter A, then to number 2, then to letter B, then to number 3, then to letter C then so forth until they connected the circles as quickly as possible, without lifting pen or pencil from the paper. Participant was timed (maximum time limit was 300 seconds or 5 minutes) to connect the &quot;trail.&quot; If the participant made an error, and it was pointed out immediately, the participant was allowed to correct it. Errors affected the participant's score only in that the correction of errors was included in the completion time for the task. A higher number of errors was indicative of a higher cognitive deficit. Raw results were the number of seconds required to complete the task; therefore, higher scores reveal greater impairment. Raw results based on age norms were transformed to Z-scores. Z-score = actual value minus normative value divided by standard deviation.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="193"/>
                <count group_id="O2" value="56"/>
                <count group_id="O3" value="154"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.25" spread="2.9"/>
                    <measurement group_id="O2" value="-0.13" spread="3.6"/>
                    <measurement group_id="O3" value="-0.59" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 3</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 3</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="686"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="237"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="686"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="237"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.93" spread="11.3"/>
                    <measurement group_id="O2" value="57.67" spread="5.5"/>
                    <measurement group_id="O3" value="59.27" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="539"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="170"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.29" spread="7.8"/>
                    <measurement group_id="O2" value="4.50" spread="13.4"/>
                    <measurement group_id="O3" value="-1.88" spread="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 6</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 6</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="467"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="166"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.53" spread="8.8"/>
                    <measurement group_id="O2" value="-1.54" spread="8.8"/>
                    <measurement group_id="O3" value="-2.74" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 12</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 12</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="370"/>
                <count group_id="O2" value="58"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.12" spread="9.1"/>
                    <measurement group_id="O2" value="-1.97" spread="8.3"/>
                    <measurement group_id="O3" value="-2.81" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 18</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 18</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="290"/>
                <count group_id="O2" value="69"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.40" spread="9.2"/>
                    <measurement group_id="O2" value="-1.57" spread="9.9"/>
                    <measurement group_id="O3" value="-3.13" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 24</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 24</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="248"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.37" spread="10.0"/>
                    <measurement group_id="O2" value="-3.14" spread="9.0"/>
                    <measurement group_id="O3" value="-4.16" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 30</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 30</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="200"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="135"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.60" spread="11.2"/>
                    <measurement group_id="O2" value="-4.39" spread="8.7"/>
                    <measurement group_id="O3" value="-4.53" spread="10.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 36</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Cognitive Function Using Metacognition Index From Behavior Rating Inventory of Executive Function (BRIEF) at Month 36</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="184"/>
                <count group_id="O2" value="54"/>
                <count group_id="O3" value="141"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.96" spread="12.1"/>
                    <measurement group_id="O2" value="-3.87" spread="10.4"/>
                    <measurement group_id="O3" value="-4.62" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 3</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 3</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="692"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="238"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="692"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="238"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.15" spread="12.0"/>
                    <measurement group_id="O2" value="58.67" spread="4.0"/>
                    <measurement group_id="O3" value="61.88" spread="12.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="544"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.08" spread="9.1"/>
                    <measurement group_id="O2" value="-1.50" spread="0.7"/>
                    <measurement group_id="O3" value="-2.39" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 6</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 6</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="472"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="167"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.06" spread="9.4"/>
                    <measurement group_id="O2" value="-3.14" spread="9.7"/>
                    <measurement group_id="O3" value="-3.62" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 12</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 12</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="373"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.42" spread="10.1"/>
                    <measurement group_id="O2" value="-2.44" spread="8.2"/>
                    <measurement group_id="O3" value="-5.01" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 18</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 18</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="294"/>
                <count group_id="O2" value="71"/>
                <count group_id="O3" value="140"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-5.21" spread="9.9"/>
                    <measurement group_id="O2" value="-3.59" spread="9.9"/>
                    <measurement group_id="O3" value="-4.48" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 24</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 24</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="252"/>
                <count group_id="O2" value="68"/>
                <count group_id="O3" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.21" spread="11.2"/>
                    <measurement group_id="O2" value="-5.78" spread="8.8"/>
                    <measurement group_id="O3" value="-6.05" spread="9.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 30</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 30</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="204"/>
                <count group_id="O2" value="61"/>
                <count group_id="O3" value="136"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.92" spread="10.8"/>
                    <measurement group_id="O2" value="-5.23" spread="10.0"/>
                    <measurement group_id="O3" value="-6.53" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 36</title>
        <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
        <time_frame>Baseline, Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Behavioral/Emotional Regulation Using the Behavior Regulation Index From BRIEF at Month 36</title>
          <description>BRIEF has 86-items to measure the neurocognitive performance for 8 subscales: inhibit, shift, emotional control, initiate, working memory, plan-organize, organization of materials and monitor. These are subsumed in 2 broad factors: a behavior regulation index consisted inhibit, shift, and emotional control subscales, a metacognition index consisted working memory, initiate, plan/organize, organization of materials, and task-monitor scale. Each item had a 3-point scale (1= never, 2= sometimes, 3= often). Z-score was based on mean raw score for T-score= 50 and SD = +/- 10. (actual value raw score at T=50)/SD (mean SD where T=40,60), based on age and gender norms from BRIEF professional manual. T-score provided information of individual's scores relative to scores of respondents in the standardization sample. Lower Z- scores indicated better functioning.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="188"/>
                <count group_id="O2" value="55"/>
                <count group_id="O3" value="142"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.44" spread="11.1"/>
                    <measurement group_id="O2" value="-7.24" spread="10.6"/>
                    <measurement group_id="O3" value="-6.22" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 3</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on centers for disease control (CDC) norms for age and gender.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 3</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on centers for disease control (CDC) norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="693"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="243"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="693"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="243"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.31" spread="1.1"/>
                    <measurement group_id="O2" value="0.76" spread="1.4"/>
                    <measurement group_id="O3" value="0.32" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="554"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="174"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.3"/>
                    <measurement group_id="O2" value="-0.03" spread="0.1"/>
                    <measurement group_id="O3" value="-0.01" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 6</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 6</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="478"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.02" spread="0.3"/>
                    <measurement group_id="O2" value="0.07" spread="0.4"/>
                    <measurement group_id="O3" value="0.00" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 12</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 12</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="381"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.01" spread="0.4"/>
                    <measurement group_id="O2" value="0.06" spread="0.5"/>
                    <measurement group_id="O3" value="-0.04" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 18</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 18</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="305"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.03" spread="0.5"/>
                    <measurement group_id="O2" value="0.00" spread="0.5"/>
                    <measurement group_id="O3" value="-0.02" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 24</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 24</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="263"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.5"/>
                    <measurement group_id="O2" value="-0.02" spread="0.6"/>
                    <measurement group_id="O3" value="-0.02" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 30</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 30</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.01" spread="0.7"/>
                    <measurement group_id="O2" value="-0.10" spread="0.6"/>
                    <measurement group_id="O3" value="0.00" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Height at Month 36</title>
        <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Height at Month 36</title>
          <description>Height was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw height measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="203"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="160"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.00" spread="0.7"/>
                    <measurement group_id="O2" value="-0.04" spread="0.7"/>
                    <measurement group_id="O3" value="-0.02" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 3</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 3</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="693"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="243"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="693"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="243"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.58" spread="1.2"/>
                    <measurement group_id="O2" value="0.88" spread="0.7"/>
                    <measurement group_id="O3" value="0.42" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="554"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="173"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.2"/>
                    <measurement group_id="O2" value="-0.22" spread="0.1"/>
                    <measurement group_id="O3" value="-0.03" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 6</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 6</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="478"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.03" spread="0.3"/>
                    <measurement group_id="O2" value="0.01" spread="0.3"/>
                    <measurement group_id="O3" value="-0.05" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 12</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 12</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="382"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.10" spread="0.4"/>
                    <measurement group_id="O2" value="0.06" spread="0.5"/>
                    <measurement group_id="O3" value="0.00" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 18</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 18</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="305"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="0.5"/>
                    <measurement group_id="O2" value="0.07" spread="0.6"/>
                    <measurement group_id="O3" value="-0.01" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 24</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 24</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="263"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.5"/>
                    <measurement group_id="O2" value="0.15" spread="0.6"/>
                    <measurement group_id="O3" value="0.00" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 30</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 30</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.6"/>
                    <measurement group_id="O2" value="0.11" spread="0.6"/>
                    <measurement group_id="O3" value="0.04" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Weight at Month 36</title>
        <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Weight at Month 36</title>
          <description>Weight was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw weight measurements were norm-adjusted transformed to Z-score using formula: Z-score= actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="203"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="162"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.6"/>
                    <measurement group_id="O2" value="0.17" spread="0.7"/>
                    <measurement group_id="O3" value="0.02" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 3</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 3</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="693"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="243"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="693"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="243"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.48" spread="1.3"/>
                    <measurement group_id="O2" value="0.79" spread="0.4"/>
                    <measurement group_id="O3" value="0.27" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="554"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="173"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02" spread="0.3"/>
                    <measurement group_id="O2" value="-0.26" spread="0.2"/>
                    <measurement group_id="O3" value="-0.03" spread="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 6</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 6</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="478"/>
                <count group_id="O2" value="36"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04" spread="0.4"/>
                    <measurement group_id="O2" value="-0.03" spread="0.4"/>
                    <measurement group_id="O3" value="-0.06" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 12</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 12</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="381"/>
                <count group_id="O2" value="59"/>
                <count group_id="O3" value="144"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.13" spread="0.5"/>
                    <measurement group_id="O2" value="0.06" spread="0.6"/>
                    <measurement group_id="O3" value="0.04" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 18</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 18</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="305"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="145"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.18" spread="0.6"/>
                    <measurement group_id="O2" value="0.07" spread="0.8"/>
                    <measurement group_id="O3" value="-0.04" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 24</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 24</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="263"/>
                <count group_id="O2" value="70"/>
                <count group_id="O3" value="138"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.7"/>
                    <measurement group_id="O2" value="0.20" spread="0.9"/>
                    <measurement group_id="O3" value="-0.01" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 30</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 30</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="66"/>
                <count group_id="O3" value="148"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.16" spread="0.8"/>
                    <measurement group_id="O2" value="0.15" spread="0.8"/>
                    <measurement group_id="O3" value="0.03" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Body Mass Index (BMI) at Month 36</title>
        <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
        <time_frame>Baseline, Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Body Mass Index (BMI) at Month 36</title>
          <description>BMI is participant's weight in kilograms divided by the square of height in meters. BMI was measured and referenced to norms according to standardized procedures from the national health and nutrition examination survey (NHANES III). Raw BMI measurements were norm-adjusted transformed to Z-score using formula: Z-score = actual value minus normative value divided by standard deviation based on CDC norms for age and gender.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure.</population>
          <units>Z-score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="203"/>
                <count group_id="O2" value="62"/>
                <count group_id="O3" value="160"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.17" spread="0.8"/>
                    <measurement group_id="O2" value="0.21" spread="0.9"/>
                    <measurement group_id="O3" value="0.01" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Primary: Number of Participants With Tanner Staging Evaluation at Baseline: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Baseline (prior to or within 45 Days of initiating treatment, if exposed) and after parental/guardian provided permission and assent</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure. There were no male participants in reporting arm &quot;Other Antidepressant&quot; at Baseline, hence no data collected and evaluated.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Primary: Number of Participants With Tanner Staging Evaluation at Baseline: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure. There were no male participants in reporting arm &quot;Other Antidepressant&quot; at Baseline, hence no data collected and evaluated.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="288"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="113"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="122"/>
                    <measurement group_id="O3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 3: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 3: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="230"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="94"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="42"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 6: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 6: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="203"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="75"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="36"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 12: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 12: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="164"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 18: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 18: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="57"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 24: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 24: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="112"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="62"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 30: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 30: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="64"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 36: All Males</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 36: All Males</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for males in pubertal development (pubic hair, penis and testes) were assessed. Participants were evaluated for genital development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of male participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Baseline: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Baseline (prior to or within 45 Days of initiating treatment, if exposed) and after parental/guardian provided permission and assent</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Baseline: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="401"/>
                <count group_id="O2" value="3"/>
                <count group_id="O3" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="81"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="146"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 3: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 3</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 3: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="323"/>
                <count group_id="O2" value="2"/>
                <count group_id="O3" value="94"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="47"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="108"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 6: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 6</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 6: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="275"/>
                <count group_id="O2" value="22"/>
                <count group_id="O3" value="91"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="46"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="90"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="65"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 12: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 12</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 12: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="35"/>
                <count group_id="O3" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="27"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="62"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 18: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 18</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 18: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="169"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="57"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 24: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 24</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 24: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="151"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="76"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 30: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 30</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 30: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="132"/>
                <count group_id="O2" value="33"/>
                <count group_id="O3" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Tanner Staging Evaluation at Month 36: All Females</title>
        <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
        <time_frame>Month 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Tanner Staging Evaluation at Month 36: All Females</title>
          <description>Tanner stage defines physical measurements of development based on external primary and secondary sex characteristics. The physical changes for females in pubertal development were assessed. Participants were evaluated for pubic hair distribution, breast development, with values ranging from stage 1 (pre-pubertal characteristics) to stage 5 (adult or mature characteristics).</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of female participants evaluable for this outcome measure.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="120"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Stage 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Stage 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants in Each Category of Clinical Global Impression-Improvement (CGI-I) Scale at Month 3, 6, 12, 18, 24, 30 and 36</title>
        <description>CGI-I scale was a 7-point scale used to rate improvement in the participant's condition (benefits). Scale range/categories: 1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = Not changed, 5 = minimally worse, 6 = much worse, and 7 = very much worse. Higher score indicated worse condition.</description>
        <time_frame>Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants in Each Category of Clinical Global Impression-Improvement (CGI-I) Scale at Month 3, 6, 12, 18, 24, 30 and 36</title>
          <description>CGI-I scale was a 7-point scale used to rate improvement in the participant's condition (benefits). Scale range/categories: 1 = very much improved, 2 = much improved, 3 = minimally improved, 4 = Not changed, 5 = minimally worse, 6 = much worse, and 7 = very much worse. Higher score indicated worse condition.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="556"/>
                <count group_id="O2" value="73"/>
                <count group_id="O3" value="176"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="556"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="176"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="223"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="151"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="69"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="63"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="478"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="167"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="96"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="220"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="64"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="382"/>
                    <count group_id="O2" value="57"/>
                    <count group_id="O3" value="141"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="174"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="304"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="86"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="136"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="262"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="113"/>
                    <measurement group_id="O2" value="39"/>
                    <measurement group_id="O3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="214"/>
                    <count group_id="O2" value="64"/>
                    <count group_id="O3" value="143"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="102"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="203"/>
                    <count group_id="O2" value="64"/>
                    <count group_id="O3" value="154"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                    <measurement group_id="O2" value="22"/>
                    <measurement group_id="O3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="85"/>
                    <measurement group_id="O2" value="27"/>
                    <measurement group_id="O3" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Improved</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Changed</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Minimally Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Much Worse</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants in Each Category of Clinical Global Impression-Tolerability (CGI-T) Scale at Month 3, 6, 12, 18, 24, 30 and 36</title>
        <description>CGI-T scale was a 7-point scale used to assess the tolerability of the study medication with respect to adverse events. Scale range/categories: 1= very high, 2= high, 3= above average, 4= average, 5= low, 6= very low, and 7= extremely low. Higher score indicated less tolerability with study medication.</description>
        <time_frame>Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants in Each Category of Clinical Global Impression-Tolerability (CGI-T) Scale at Month 3, 6, 12, 18, 24, 30 and 36</title>
          <description>CGI-T scale was a 7-point scale used to assess the tolerability of the study medication with respect to adverse events. Scale range/categories: 1= very high, 2= high, 3= above average, 4= average, 5= low, 6= very low, and 7= extremely low. Higher score indicated less tolerability with study medication.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="546"/>
                <count group_id="O2" value="65"/>
                <count group_id="O3" value="96"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="546"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="96"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="274"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="123"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="40"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="468"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="95"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="245"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="49"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="367"/>
                    <count group_id="O2" value="52"/>
                    <count group_id="O3" value="74"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="217"/>
                    <measurement group_id="O2" value="23"/>
                    <measurement group_id="O3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="84"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="298"/>
                    <count group_id="O2" value="64"/>
                    <count group_id="O3" value="69"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="170"/>
                    <measurement group_id="O2" value="32"/>
                    <measurement group_id="O3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="250"/>
                    <count group_id="O2" value="65"/>
                    <count group_id="O3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="149"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="67"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="57"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="132"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="18"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="197"/>
                    <count group_id="O2" value="56"/>
                    <count group_id="O3" value="58"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Very High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="125"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>High</title>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Above Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="11"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Average</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Very Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Extremely Low</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Were Responders According to Clinical Global Impression-Effectiveness (CGI-E) Scale at Month 3, 6, 12, 18, 24, 30 and 36</title>
        <description>The CGI-E was the value at which the participant's therapeutic benefit and adverse impact to the study drug intersected. Firstly clinician identified the degree of therapeutic benefit on scale range: very much improved, much improved, minimally improved, unchanged or worse. Secondly, the clinician rater identified the degree to which problems with tolerability adversely impact the participant on scale range: no adverse impact, mild adverse impact, moderate adverse impact, outweighs therapeutic effect. Finally, clinician identified in which participants benefits and adverse impacts intersected. Participants were then determined to be responders or non-responders to the study medication.</description>
        <time_frame>Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Were Responders According to Clinical Global Impression-Effectiveness (CGI-E) Scale at Month 3, 6, 12, 18, 24, 30 and 36</title>
          <description>The CGI-E was the value at which the participant's therapeutic benefit and adverse impact to the study drug intersected. Firstly clinician identified the degree of therapeutic benefit on scale range: very much improved, much improved, minimally improved, unchanged or worse. Secondly, the clinician rater identified the degree to which problems with tolerability adversely impact the participant on scale range: no adverse impact, mild adverse impact, moderate adverse impact, outweighs therapeutic effect. Finally, clinician identified in which participants benefits and adverse impacts intersected. Participants were then determined to be responders or non-responders to the study medication.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="544"/>
                <count group_id="O2" value="67"/>
                <count group_id="O3" value="130"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Responders at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="544"/>
                    <count group_id="O2" value="2"/>
                    <count group_id="O3" value="130"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="296"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responders at Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="470"/>
                    <count group_id="O2" value="30"/>
                    <count group_id="O3" value="120"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="309"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responders at Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="372"/>
                    <count group_id="O2" value="53"/>
                    <count group_id="O3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="268"/>
                    <measurement group_id="O2" value="28"/>
                    <measurement group_id="O3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responders at Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="300"/>
                    <count group_id="O2" value="65"/>
                    <count group_id="O3" value="87"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="219"/>
                    <measurement group_id="O2" value="44"/>
                    <measurement group_id="O3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responders at Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="255"/>
                    <count group_id="O2" value="67"/>
                    <count group_id="O3" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="206"/>
                    <measurement group_id="O2" value="47"/>
                    <measurement group_id="O3" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responders at Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="212"/>
                    <count group_id="O2" value="62"/>
                    <count group_id="O3" value="79"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="173"/>
                    <measurement group_id="O2" value="52"/>
                    <measurement group_id="O3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Responders at Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="198"/>
                    <count group_id="O2" value="60"/>
                    <count group_id="O3" value="85"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="169"/>
                    <measurement group_id="O2" value="46"/>
                    <measurement group_id="O3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants in Each Category of Clinical Global Impression-Severity (CGI-S) Scale at Baseline, Month 3, 6, 12, 18, 24, 30 and 36</title>
        <description>CGI-S scale was a 7-point scale used to assess severity of illness on a range of 1 to 7; where, 1= normal, not mentally ill, 2= borderline mentally ill, 3= mildly mentally ill, 4= moderately mentally ill, 5= markedly mentally ill, 6= severely mentally ill, and 7= among the most extremely mentally. Higher score indicated worse condition.</description>
        <time_frame>Baseline, Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants in Each Category of Clinical Global Impression-Severity (CGI-S) Scale at Baseline, Month 3, 6, 12, 18, 24, 30 and 36</title>
          <description>CGI-S scale was a 7-point scale used to assess severity of illness on a range of 1 to 7; where, 1= normal, not mentally ill, 2= borderline mentally ill, 3= mildly mentally ill, 4= moderately mentally ill, 5= markedly mentally ill, 6= severely mentally ill, and 7= among the most extremely mentally. Higher score indicated worse condition.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="692"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="243"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="692"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="243"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="138"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="57"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="377"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="107"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="556"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="178"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="163"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="216"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="55"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="479"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="44"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="93"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="139"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="162"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="43"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="31"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="383"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="32"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="133"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="39"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="26"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="304"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="66"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="106"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="76"/>
                    <measurement group_id="O2" value="33"/>
                    <measurement group_id="O3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="263"/>
                    <count group_id="O2" value="71"/>
                    <count group_id="O3" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="39"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="100"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="48"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="218"/>
                    <count group_id="O2" value="66"/>
                    <count group_id="O3" value="148"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="78"/>
                    <measurement group_id="O2" value="25"/>
                    <measurement group_id="O3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="19"/>
                    <measurement group_id="O3" value="29"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="204"/>
                    <count group_id="O2" value="64"/>
                    <count group_id="O3" value="163"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Normal, Not Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Borderline Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="54"/>
                    <measurement group_id="O2" value="13"/>
                    <measurement group_id="O3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mildly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="20"/>
                    <measurement group_id="O3" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Moderately Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="33"/>
                    <measurement group_id="O2" value="16"/>
                    <measurement group_id="O3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Markedly Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Severely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Among the Most Extremely Mentally ill</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in Child Global Assessment Scale (CGAS) at Month 3, 6, 12, 18, 24, 30 and 36</title>
        <description>CGAS was to rate the general functioning of the study participants on a numeric scale of 1 to 100, where 1= extremely impaired and 100= doing very well.</description>
        <time_frame>Baseline, Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Child Global Assessment Scale (CGAS) at Month 3, 6, 12, 18, 24, 30 and 36</title>
          <description>CGAS was to rate the general functioning of the study participants on a numeric scale of 1 to 100, where 1= extremely impaired and 100= doing very well.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Units on scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="691"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="243"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="691"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="243"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.80" spread="10.0"/>
                    <measurement group_id="O2" value="56.67" spread="5.8"/>
                    <measurement group_id="O3" value="59.86" spread="10.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="554"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="178"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.58" spread="10.8"/>
                    <measurement group_id="O2" value="-7.67" spread="8.7"/>
                    <measurement group_id="O3" value="4.61" spread="9.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="478"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="171"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.24" spread="11.6"/>
                    <measurement group_id="O2" value="1.08" spread="16.5"/>
                    <measurement group_id="O3" value="8.23" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="382"/>
                    <count group_id="O2" value="58"/>
                    <count group_id="O3" value="146"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.02" spread="12.6"/>
                    <measurement group_id="O2" value="4.48" spread="9.4"/>
                    <measurement group_id="O3" value="10.66" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="303"/>
                    <count group_id="O2" value="74"/>
                    <count group_id="O3" value="149"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.51" spread="11.7"/>
                    <measurement group_id="O2" value="6.76" spread="10.5"/>
                    <measurement group_id="O3" value="12.46" spread="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="262"/>
                    <count group_id="O2" value="71"/>
                    <count group_id="O3" value="139"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.29" spread="12.0"/>
                    <measurement group_id="O2" value="8.44" spread="11.3"/>
                    <measurement group_id="O3" value="11.29" spread="12.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="218"/>
                    <count group_id="O2" value="66"/>
                    <count group_id="O3" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.37" spread="13.1"/>
                    <measurement group_id="O2" value="9.94" spread="11.4"/>
                    <measurement group_id="O3" value="12.54" spread="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="204"/>
                    <count group_id="O2" value="64"/>
                    <count group_id="O3" value="163"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.05" spread="12.9"/>
                    <measurement group_id="O2" value="8.77" spread="10.7"/>
                    <measurement group_id="O3" value="15.28" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in General Health and Social Functioning Using the Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) Total Score at Month 3, 6, 12, 18, 24, 30 and 36</title>
        <description>HoNOSCA scale had 13-sub-scales used to assess general health and social functioning. 13 sub-scales were as the following: disruptive or aggressive behavior, attention deficit hyperactivity disorder (ADHD), self-harm, substance abuse, school problems, physical illness, psychosis, physical symptoms, internalizing symptoms, peer relationships, self-care, family relationships and school attendance problems. Each sub-scale had a range of 0 (no problems) to 4 (severe problems). Scores from all 13 sub-scales were summed up to give overall possible HoNOSCA total score range of 0 to 52. Higher score indicated worse condition.</description>
        <time_frame>Baseline, Month 3, 6, 12, 18, 24, 30 and 36</time_frame>
        <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Sertraline</title>
            <description>At baseline, participants in this group were those at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician. At a visit post baseline, participants in this group were on sertraline only or sertraline and any other treatment since the previous visit.</description>
          </group>
          <group group_id="O2">
            <title>Other Antidepressants</title>
            <description>At baseline, use of other antidepressants at baseline was a study exclusion criterion. However, a few participants were enrolled and initiated treatment with an antidepressant other than sertraline, and hence included in this group. At a visit post baseline, participants in this group were on another antidepressant only or on another antidepressant and psychotherapy since the previous visit.</description>
          </group>
          <group group_id="O3">
            <title>Psychotherapy</title>
            <description>At baseline, participants in this group were on psychotherapy only and were those who 1) were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication. At a visit post baseline, participants in this group were those on psychotherapy only or no treatment at all since the previous visit.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in General Health and Social Functioning Using the Health of the Nation Outcome Scale for Children and Adolescents (HoNOSCA) Total Score at Month 3, 6, 12, 18, 24, 30 and 36</title>
          <description>HoNOSCA scale had 13-sub-scales used to assess general health and social functioning. 13 sub-scales were as the following: disruptive or aggressive behavior, attention deficit hyperactivity disorder (ADHD), self-harm, substance abuse, school problems, physical illness, psychosis, physical symptoms, internalizing symptoms, peer relationships, self-care, family relationships and school attendance problems. Each sub-scale had a range of 0 (no problems) to 4 (severe problems). Scores from all 13 sub-scales were summed up to give overall possible HoNOSCA total score range of 0 to 52. Higher score indicated worse condition.</description>
          <population>Analysis population included all participants in the database who had informed consent. Here, &quot;Overall Number of Participants Analyzed&quot; signifies number of participants evaluable for this outcome measure and &quot;Number Analyzed&quot; signifies number of participants evaluable at specified time points.</population>
          <units>Units on scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="685"/>
                <count group_id="O2" value="72"/>
                <count group_id="O3" value="241"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="685"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="241"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.51" spread="5.4"/>
                    <measurement group_id="O2" value="8.33" spread="3.2"/>
                    <measurement group_id="O3" value="9.19" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="542"/>
                    <count group_id="O2" value="3"/>
                    <count group_id="O3" value="172"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.75" spread="4.8"/>
                    <measurement group_id="O2" value="4.33" spread="6.4"/>
                    <measurement group_id="O3" value="-2.05" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="469"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="169"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.23" spread="5.1"/>
                    <measurement group_id="O2" value="-0.14" spread="6.0"/>
                    <measurement group_id="O3" value="-3.21" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 12</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="377"/>
                    <count group_id="O2" value="59"/>
                    <count group_id="O3" value="144"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.79" spread="5.5"/>
                    <measurement group_id="O2" value="-2.46" spread="5.8"/>
                    <measurement group_id="O3" value="-3.88" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 18</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="298"/>
                    <count group_id="O2" value="72"/>
                    <count group_id="O3" value="144"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.98" spread="5.6"/>
                    <measurement group_id="O2" value="-3.53" spread="5.8"/>
                    <measurement group_id="O3" value="-3.79" spread="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 24</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="257"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="136"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.96" spread="5.4"/>
                    <measurement group_id="O2" value="-5.07" spread="6.0"/>
                    <measurement group_id="O3" value="-4.57" spread="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 30</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="210"/>
                    <count group_id="O2" value="65"/>
                    <count group_id="O3" value="147"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.04" spread="4.8"/>
                    <measurement group_id="O2" value="-4.75" spread="4.6"/>
                    <measurement group_id="O3" value="-4.80" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change at Month 36</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="201"/>
                    <count group_id="O2" value="62"/>
                    <count group_id="O3" value="162"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.33" spread="5.3"/>
                    <measurement group_id="O2" value="-4.69" spread="4.7"/>
                    <measurement group_id="O3" value="-5.30" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Baseline up to 36 Months</time_frame>
      <desc>Same event may appear as AE and serious AE, what is presented are distinct events. Event may be categorized as serious in 1 participant and as non-serious in another participant or 1 participant may have experienced both serious and non-serious event during study. Safety analysis population at each visit for respective arms was evaluated. Since participants switched from 1 treatment to another, hence at each visit participants analyzed were different from previous visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>Sertraline (Baseline)</title>
          <description>Participants at Baseline (Day 1) or within 45 days of enrollment, initiated treatment with sertraline in routine clinical settings according to USPI provided by their physician.</description>
        </group>
        <group group_id="E2">
          <title>Other Antidepressants (Baseline)</title>
          <description>Use of other antidepressants at baseline was a study exclusion criterion, however, a few participants were enrolled who initiated treatment with an antidepressant.</description>
        </group>
        <group group_id="E3">
          <title>Psychotherapy (Baseline)</title>
          <description>Participants, 1) who were not taking sertraline or who failed a trial of sertraline judged adequate in dose and duration, and 2) initiated psychosocial rather than pharmacological treatment on or within 45 days of enrollment, for the same spectrum of mental health conditions that could have been treated with a SSRI medication.</description>
        </group>
        <group group_id="E4">
          <title>Sertraline (Month 3)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 3 visit.</description>
        </group>
        <group group_id="E5">
          <title>Other Antidepressants (Month 3)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 3 visit.</description>
        </group>
        <group group_id="E6">
          <title>Psychotherapy (Month 3)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 3 visit.</description>
        </group>
        <group group_id="E7">
          <title>Sertraline (Month 6)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 6 visit.</description>
        </group>
        <group group_id="E8">
          <title>Other Antidepressants (Month 6)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 6 visit.</description>
        </group>
        <group group_id="E9">
          <title>Psychotherapy (Month 6)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 6 visit.</description>
        </group>
        <group group_id="E10">
          <title>Sertraline (Month 12)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 12 visit.</description>
        </group>
        <group group_id="E11">
          <title>Other Antidepressants (Month 12)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 12 visit.</description>
        </group>
        <group group_id="E12">
          <title>Psychotherapy (Month 12)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 12 visit.</description>
        </group>
        <group group_id="E13">
          <title>Sertraline (Month 18)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 18 visit.</description>
        </group>
        <group group_id="E14">
          <title>Other Antidepressants (Month 18)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 18 visit.</description>
        </group>
        <group group_id="E15">
          <title>Psychotherapy (Month 18)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 18 visit.</description>
        </group>
        <group group_id="E16">
          <title>Sertraline (Month 24)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 24 visit.</description>
        </group>
        <group group_id="E17">
          <title>Other Antidepressants (Month 24)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 24 visit.</description>
        </group>
        <group group_id="E18">
          <title>Psychotherapy (Month 24)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 24 visit.</description>
        </group>
        <group group_id="E19">
          <title>Sertraline (Month 30)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 30 visit.</description>
        </group>
        <group group_id="E20">
          <title>Other Antidepressants (Month 30)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 30 visit.</description>
        </group>
        <group group_id="E21">
          <title>Psychotherapy (Month 30)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 30 visit.</description>
        </group>
        <group group_id="E22">
          <title>Sertraline (Month 36)</title>
          <description>Participants in this group were on sertraline only or sertraline and any other treatment at Month 36 visit.</description>
        </group>
        <group group_id="E23">
          <title>Other Antidepressants (Month 36)</title>
          <description>Participants in this group were on another antidepressant only or another antidepressant and psychotherapy at Month 36 visit.</description>
        </group>
        <group group_id="E24">
          <title>Psychotherapy (Month 36)</title>
          <description>Participants in this group were on psychotherapy only or no treatment at all at Month 36 visit.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA v23.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="27" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="11" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="11" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="4" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="4" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Drug ineffective</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Post concussion syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Liver function test increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Anticholinergic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Serotonin syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Anger</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Emotional disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Homicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Self-injurious ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Suicidal behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="3" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="3" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="3" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Suicide attempt</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Behaviour disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Conversion disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hostility</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Substance-induced psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA v23.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="201" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="54" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="153" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="47" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="118" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="18" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="42" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="88" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="20" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="33" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="57" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="19" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="31" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="47" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="12" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="23" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="28" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="6" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="29" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Albright's disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Eustachian tube dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Precocious puberty</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="9" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="5" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Eructation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Cheilitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="8" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Drug ineffective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Treatment noncompliance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Feeling jittery</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Food allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>H1N1 influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Impetigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Tonsillitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Croup infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Mononucleosis syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Eye infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Back injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Corneal abrasion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Intentional product misuse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Medication error</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Concussion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Post-traumatic neck syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Bone contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Ligament rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sunburn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="13" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Increased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="4" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Spondylolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Akathisia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="12" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="6" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="9" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="10" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="3" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="3" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="19" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="16" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="7" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="2" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="3" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hypersomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Psychomotor hyperactivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Febrile convulsion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Poor quality sleep</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sedation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="26" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="33" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="19" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="15" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="14" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="8" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="4" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Depressed mood</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="23" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="14" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="5" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="7" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="5" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="4" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hostility</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="22" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="6" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="17" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="11" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="9" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="3" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="2" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="29" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="21" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="7" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="9" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="6" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="4" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="5" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Nightmare</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Abnormal dreams</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Affect lability</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="5" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Aggression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="3" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="3" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Apathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Blunted affect</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Compulsions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dermatillomania</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Enuresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Euphoric mood</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Frustration tolerance decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Impulsive behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="10" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="3" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="1" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Intentional self-injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="15" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="9" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="4" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="2" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Social avoidant behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="8" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="3" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="2" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="3" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Tachyphrenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Tic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="2" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Trichotillomania</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Violence-related symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Mood swings</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Obsessive-compulsive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Obsessive-compulsive symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Oppositional defiant disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Paranoia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Restlessness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Self-injurious ideation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Thinking abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Antisocial behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="2" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Communication disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Conversion disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dysphoria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Emotional distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Purging</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Defiant behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Disinhibition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Emotional disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Learning disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Obsessive thoughts</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sleep terror</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Attention-seeking behaviour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Behaviour disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hallucinations, mixed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Incontinence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Urinary hesitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Breast disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sexual dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Menstruation irregular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="1" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="1" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="6" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="2" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="4" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="1" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="1" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Fight in school</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="614"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="3"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="622"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="19"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="384"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="516"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="426"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="80"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="181"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="335"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="84"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="289"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="83"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E19" subjects_affected="0" subjects_at_risk="240"/>
                <counts group_id="E20" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E21" subjects_affected="0" subjects_at_risk="181"/>
                <counts group_id="E22" subjects_affected="0" subjects_at_risk="207"/>
                <counts group_id="E23" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E24" subjects_affected="0" subjects_at_risk="181"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Pfizer ClinicalTrials.gov Call Center</name_or_title>
      <organization>Pfizer Inc.</organization>
      <phone>1-800-718-1021</phone>
      <email>ClinicalTrials.gov_Inquiries@pfizer.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

